CHARLES KARPINSKI: Open Payments
NPI 1508425919 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 22 payments from 15 companies in 2025. Trend: 2023 $516 · 2024 $393 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $66 |
| Abbott Laboratories | 2 | $43 |
| Exact Sciences Corporation | 2 | $41 |
| PFIZER INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| ACADIA Pharmaceuticals Inc | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: Rybelsus, FREESTYLE LIBRE 3, Cologuard Collection Kit, NUPLAZID, TRELEGY ELLIPTA, INSPIRE, GIVLAARI, JARDIANCE.
Industry payments across NY — which companies pay providers there.
